Author Correction: GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liability

Affiliations

• ¹ Behavioural Science Institute, Radboud University, Nijmegen, The Netherlands.
• ² Amsterdam UMC, University of Amsterdam, Department of Psychiatry, Amsterdam, The Netherlands.
• ³ Genetic Epidemiology, Statistical Genetics, and Translational Neurogenomics Laboratories, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
• ⁴ Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
• ⁵ Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.
• ⁶ MRC Integrative Epidemiology Unit (IEU), University of Bristol, Bristol, UK.
• ⁷ Department of Biological Psychology/Netherlands Twin Register, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
• ⁸ MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, UK.
• ⁹ 23andMe, Inc., Mountain View, CA, USA.
• ¹⁰ Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL, USA.
• ¹¹ Vanderbilt Genetics Institute; Division of Genetic Medicine, Department of Medicine, Vanderbilt University, Nashville, TN, USA.
• ¹² Peter Boris Centre for Addictions Research and Michael G. DeGroote Centre for Medicinal Cannabis Research, McMaster University/St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.
• ¹³ Department of Psychology, University of Illinois Urbana-Champaign, Champaign, IL, USA.
• ¹⁴ Department of Youth and Family, Utrecht University, Utrecht, the Netherlands.
• ¹⁵ Department of Psychiatry, Interdisciplinary Center Psychopathology and Emotion Regulation, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
• ¹⁶ Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
• ¹⁷ Department of Developmental Psychology and EMGO Institute for Health and Care Research, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
• ¹⁸ Estonian Genome Center, University of Tartu, Tartu, Estonia.
• ¹⁹ Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.
• ²⁰ Hospital for Sick Children, Toronto, Ontario, Canada.
• ²¹ Psychiatric Genetics Unit, Group of Psychiatry, Mental Health and Addiction, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
• ²² Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
• ²³ Biomedical Network Research Centre on Mental Health (CIBERSAM), Instituto de Salud Carlos III, Barcelona, Spain.
• ²⁴ Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
• ²⁵ Rotman Research Institute, Baycrest, Toronto, Ontario, Canada.
• ²⁶ Departments of Psychology and Psychiatry, University of Toronto, Toronto, Ontario, Canada.
• ²⁷ Institute for Molecular Medicine Finland FIMM, HiLIFE Unit, University of Helsinki, Helsinki, Finland.
• ²⁸ Brain Center Rudolf Magnus, Department of Psychiatry, University Medical Center Utrecht, Utrecht, The Netherlands.
• ²⁹ Department of Twin Research and Genetic Epidemiology, King's College London, London, UK.
• ³⁰ Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
• ³¹ Institute for Genomic Medicine, University of California San Diego, La Jolla, CA, USA.
• ³² UK Centre for Tobacco and Alcohol Studies and School of Experimental Psychology, University of Bristol, Bristol, UK.
• ³³ Department of Psychiatry, Virginia Institute for Psychiatric and Behavior Genetics, Virginia Commonwealth University, Richmond, VA, USA.
• ³⁴ Behavioural Science Institute, Radboud University, Nijmegen, The Netherlands. j.vink@bsi.ru.nl.